A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This is a single-center, open, single-dose, self-controlled phase I clinical trial to
evaluate the effects of Itraconazole Capsules/Rifampicin Capsules on pharmacokinetics of
TQB3909 tablets in vivo, and the safety of TQB3909 tablets and combined with Itraconazole
Capsules/Rifampicin Capsules after single oral dose.